NYSE:AMRX
Amneal Pharmaceuticals, Inc.
- Stock
Last Close
5.40
24/04 20:00
Market Cap
1.68B
Beta: 1.32
Volume Today
2.91M
Avg: 1.09M
PE Ratio
151.43
PFCF: 12.36
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
revenue | 1.02B - | 1.03B 1.52% | 1.66B 60.88% | 1.63B 2.20% | 1.99B 22.51% | 2.09B 5.08% | 2.21B 5.67% | 2.39B 8.20% | |
cost of revenue | 420.77M - | 507.48M 20.61% | 946.59M 86.53% | 1.27B 34.52% | 1.36B 7.13% | 1.32B 2.89% | 1.43B 7.77% | 1.57B 10.19% | |
gross profit | 597.46M - | 526.18M 11.93% | 716.40M 36.15% | 353.00M 50.73% | 628.39M 78.02% | 768.97M 22.37% | 784.71M 2.05% | 820.57M 4.57% | |
selling and marketing expenses | |||||||||
general and administrative expenses | 118.76M - | 109.05M 8.18% | 230.44M 111.32% | ||||||
selling general and administrative expenses | 118.76M - | 109.05M 8.18% | 230.44M 111.32% | 289.60M 25.67% | 326.73M 12.82% | 365.50M 11.87% | 399.70M 9.36% | 429.68M 7.50% | |
research and development expenses | 204.75M - | 191.94M 6.26% | 210.45M 9.65% | 202.29M 3.88% | 190.59M 5.78% | 209.56M 9.96% | 200.05M 4.54% | 167.78M 16.13% | |
other expenses | -669K - | -47K 92.97% | 2.85M 6,159.57% | 1.47M 48.56% | 2.59M 76.79% | 15.33M 491.89% | -3.96M 125.83% | 5.12M 229.27% | |
cost and expenses | 744.27M - | 808.46M 8.62% | 1.39B 71.62% | 1.77B 27.23% | 1.88B 6.58% | 1.90B 0.97% | 2.02B 6.51% | 2.17B 7.21% | |
operating expenses | 323.50M - | 300.98M 6.96% | 440.89M 46.48% | 491.88M 11.57% | 517.31M 5.17% | 575.07M 11.16% | 595.79M 3.60% | 596.32M 0.09% | |
interest expense | 55.28M - | 71.06M 28.54% | 143.57M 102.04% | 168.21M 17.16% | 146.00M 13.20% | 136.32M 6.63% | 158.38M 16.18% | 210.63M 32.99% | |
ebitda | 306.30M - | 271.08M 11.50% | 415.77M 53.37% | 69.81M 83.21% | 349.06M 400.00% | 442.64M 26.81% | 446.64M 0.90% | 417.96M 6.42% | |
operating income | 284.88M - | 245.10M 13.96% | -19.67M 108.03% | -137.42M 598.54% | 91.16M 166.33% | 209.24M 129.54% | 206.46M 1.32% | 204.37M 1.01% | |
depreciation and amortization | 33.02M - | 45.94M 39.13% | 137.40M 199.12% | 207.24M 50.82% | 257.90M 24.45% | 233.41M 9.50% | 240.18M 2.90% | 229.40M 4.49% | |
total other income expenses net | -3.85M - | 17.19M 546.84% | -334.67M 2,046.88% | -82.82M 75.25% | -126.94M 53.27% | -177.87M 40.13% | -454.59M 155.57% | -13.09M 97.12% | |
income before tax | 214.82M - | 171.32M 20.25% | -202.72M 218.33% | -220.24M 8.64% | -35.78M 83.75% | 31.37M 187.66% | -248.13M 891.07% | -40.27M 83.77% | |
income tax expense | 5.39M - | 2.00M 62.97% | -1.42M 171.02% | 383.33M 27,114.16% | -104.36M 127.22% | 11.20M 110.73% | 6.66M 40.50% | 8.45M 26.87% | |
net income | 207.38M - | 167.65M 19.16% | -169.73M 201.24% | -603.57M 255.62% | 68.58M 111.36% | 20.17M 70.59% | -254.79M 1,363.21% | -83.99M 67.03% | |
weighted average shs out | 114.86M - | 114.86M 0% | 127.25M 10.79% | 132.09M 3.80% | 147.44M 11.63% | 148.92M 1.00% | 150.94M 1.36% | 176.14M 16.69% | |
weighted average shs out dil | 114.86M - | 114.86M 0% | 127.25M 10.79% | 132.11M 3.81% | 148.91M 12.72% | 151.82M 1.95% | 150.94M 0.58% | 176.14M 16.69% | |
eps | 1.81 - | 1.46 19.34% | -1.33 191.10% | -4.57 243.61% | 0.47 110.28% | 0.14 70.21% | -1.69 1,307.14% | -0.48 71.60% | |
epsdiluted | 1.81 - | 1.46 19.34% | -1.33 191.10% | -4.57 243.61% | 0.46 110.07% | 0.13 71.74% | -1.69 1,400.00% | -0.48 71.60% |
All numbers in USD (except ratios and percentages)